Clinical outcomes of sacituzumab govitecan in older patients with metastatic triple-negative breast cancer: a multinational real-world study.
- DOI
- 10.1093/oncolo/oyag281
- Published
- 2026 Aug 6
- Container
- The oncologist
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/oncolo/oyag281,
title = {Clinical outcomes of sacituzumab govitecan in older patients with metastatic triple-negative breast cancer: a multinational real-world study.},
author = {Konieczna A and Pieniążek M and Żubrowska J and Polakiewicz-Gilowska A and Soumarová R and Holánek M and Študentová H and Młodzińska A and Winsko-Szczęsnowicz K and Lisik-Habib M and Pękala A and Krejčí D and Šustr J and Kolářová I and Danielewicz I and Szymanik-Resko M and Ciszewski T and Rušinová L and Czartoryska-Arłukowicz B and Łacko A and Jarząb M and Kubeczko M and Pacholczak-Madej R and Smok-Kalwat J and Nowecki Z and Bielčiková Z and Malejčíková M and Püsküllüoğlu M},
year = {2026},
journal = {The oncologist},
doi = {10.1093/oncolo/oyag281},
url = {https://doi.org/10.1093/oncolo/oyag281}
}RIS
TY - JOUR TI - Clinical outcomes of sacituzumab govitecan in older patients with metastatic triple-negative breast cancer: a multinational real-world study. AU - Konieczna A AU - Pieniążek M AU - Żubrowska J AU - Polakiewicz-Gilowska A AU - Soumarová R AU - Holánek M AU - Študentová H AU - Młodzińska A AU - Winsko-Szczęsnowicz K AU - Lisik-Habib M AU - Pękala A AU - Krejčí D AU - Šustr J AU - Kolářová I AU - Danielewicz I AU - Szymanik-Resko M AU - Ciszewski T AU - Rušinová L AU - Czartoryska-Arłukowicz B AU - Łacko A AU - Jarząb M AU - Kubeczko M AU - Pacholczak-Madej R AU - Smok-Kalwat J AU - Nowecki Z AU - Bielčiková Z AU - Malejčíková M AU - Püsküllüoğlu M PY - 2026 JO - The oncologist DO - 10.1093/oncolo/oyag281 UR - https://doi.org/10.1093/oncolo/oyag281 ER -
APA
A, K., M, P., J, Ż., A, P., R, S., M, H., H, Š., A, M., K, W., M, L., A, P., D, K., J, Š., I, K., I, D., M, S., T, C., L, R., B, C., A, Ł., M, J., M, K., R, P., J, S., Z, N., Z, B., M, M., & M, P. (2026). Clinical outcomes of sacituzumab govitecan in older patients with metastatic triple-negative breast cancer: a multinational real-world study.. The oncologist. https://doi.org/10.1093/oncolo/oyag281
Source records
- pubmed · retrieved 2026-09-26T23:11:54.630Z